Health Communication and Integrated Corporate Social Responsibility
Isabell Koinig (),
Sandra Diehl () and
Barbara Mueller ()
Additional contact information
Isabell Koinig: Alpen-Adria-Universität Klagenfurt
Sandra Diehl: Klagenfurt University
Barbara Mueller: San Diego State University
A chapter in Handbook of Integrated CSR Communication, 2017, pp 471-494 from Springer
Abstract:
Abstract Health communication has experienced a revival in the twenty-first century, which has been labeled the “health communication renaissance”. At the same time, public concern regarding social causes is on the rise. In response, pharmaceutical marketers have begun to publicly proclaim their support for social and environmental causes. Due to declining public trust in their products as well as their commercial messages for these products, together with increasing legal restrictions, pharmaceutical marketers are being forced to rethink their business and promotional strategies. Consumers’ roles have changed as well; today’s “new consumers” are more skeptical and demanding, renowned for rewarding corporations for their sustainable and future-oriented projects, while punishing those who fail to engage in them. This chapter examines whether corporate social responsibility (CSR) appeals—defined as socially and/or environmentally-oriented efforts promoted as part of corporations’ advertising messages—present a fruitful strategy for the health communication field in general, and for pharmaceutical manufacturers in particular. To this end, two studies are presented here, which investigate how integrated promotional CSR messages are utilized and perceived in a cross-cultural setting. Results indicate that (1) to date, social and green appeals do not constitute a dominant message appeal category in the pharmaceutical industry, and, (2) while CSR appeals in pharmaceutical ads resonated with consumers in the U.S. and Brazil, they were looked upon less favorably by German respondents. This suggests that pharmaceutical marketers intending to incorporate CSR appeals in their commercial messages should tailor such messages to the respective country. In conclusion, limitations are addressed and suggestions for further research are provided.
Keywords: CSR; Socially conscious consumer; Health Communication; Pharmaceutical advertising; CSR communication; Cross-cultural study (search for similar items in EconPapers)
Date: 2017
References: Add references at CitEc
Citations:
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:csrchp:978-3-319-44700-1_26
Ordering information: This item can be ordered from
http://www.springer.com/9783319447001
DOI: 10.1007/978-3-319-44700-1_26
Access Statistics for this chapter
More chapters in CSR, Sustainability, Ethics & Governance from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().